Unibest 优贝德
登录 / 注册
← 返回专利悬崖列表

CAS 1782959-00-5

(3aS,9aS,10S,12S,13S,13aR,13bS)-13-Hydroxy-13-(hydroxymethyl)-6,9a,14,14-tetramethyl-2,8-dioxo-10-[(triethylsilyl)oxy]-5,8,9,9a,10,11,12,13,13a,13b-decahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-12-yl methanesulfonate

登记编号:(XXII)101438-13-b

应用背景(按来源药适应症)

乳腺癌Paclitaxel/Encequidar mesylate腺癌Paclitaxel/Encequidar mesylate血管肉瘤Paclitaxel/Encequidar mesylate实体瘤Paclitaxel/Encequidar mesylate

来源药(使用该中间体的合成路线)

品种梯队到期年
Paclitaxel/Encequidar mesylatePaclitaxel/Encequidar mesylateTier C · 观察 / 贸易-

合成路线中的位置(上下游链)

按路线登记顺序排列,左→右为合成方向;高亮为当前 CAS,其余可点击跳转对应档案。

Paclitaxel/Encequidar mesylate优化路线步数:9总收率:/
(2alpha,5beta,7beta,10beta)-1,2,7,10-Tetrahydroxytaxa-4(20),11-dien-5-yl acetate→1-[(1H-Imidazol-1-yl)carbonyl]1H-imidazole→(3aS,9aS,10S,12R,13S,13aR,13bS)-12,13-Dihydroxy-13-(hydroxymethyl)-6,9a,14,14-tetramethyl-10-[(triethylsilyl)oxy]-9,9a,10,11,12,13,13a,13b-octahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxole-2,8(5H)-dione→(3aS,8S,9aS,10S,12R,13aR,13bS)-8,10-Dihydroxy-6,9a,14,14-tetramethyl-13-methylene-2-oxo-5,8,9,9a,10,11,12,13,13a,13b-decahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-12-yl acetate→(3aS,8S,9aS,10S,12R,13aR,13bS)-8-Hydroxy-6,9a,14,14-tetramethyl-13-methylene-2-oxo-10-[(triethylsilyl)oxy]-5,8,9,9a,10,11,12,13,13a,13b-decahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-12-yl acetate→(3aS,9aS,10S,12R,13aR,13bS)-6,9a,14,14-Tetramethyl-13-methylene-2,8-dioxo-10-[(triethylsilyl)oxy]-5,8,9,9a,10,11,12,13,13a,13b-decahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-12-yl acetate→(3aS,9aS,10S,12S,13aR,13bS)-12-Hydroxy-6,9a,14,14-tetramethyl-13-methylene-10-[(triethylsilyl)oxy]-9,9a,10,11,12,13,13a,13b-octahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxole-2,8(5H)-dione→[(3aS,9aS,10S,12R,13S,13aR,13bS)-12,13-Dihydroxy-6,9a,14,14-tetramethyl-2,8-dioxo-10-[(triethylsilyl)oxy]-5,8,9,9a,10,11,12,13,13a,13b-decahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-13-yl]methyl acetate→[(3aS,9aS,10S,12R,13S,13aR,13bS)-13-Hydroxy-6,9a,14,14-tetramethyl-12-[(methylsulfonyl)oxy]-2,8-dioxo-10-[(triethylsilyl)oxy]-5,8,9,9a,10,11,12,13,13a,13b-decahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-13-yl]methyl acetate→(3aS,9aS,10S,12S,13S,13aR,13bS)-13-Hydroxy-13-(hydroxymethyl)-6,9a,14,14-tetramethyl-2,8-dioxo-10-[(triethylsilyl)oxy]-5,8,9,9a,10,11,12,13,13a,13b-decahydro-4H-3a,7-methanobenzo[3,4]cyclodeca[1,2-d][1,3]dioxol-12-yl methanesulfonate→(3aS,9aS,10S,11aR,13aS,13bR,13cS)-13a-Hydroxy-6,9a,14,14-tetramethyl-10-[(triethylsilyl)oxy]-4,5,9a,10,11,11a,13,13a,13b,13c-decahydro-3a,7-methano[1,3]dioxolo[9,10]cyclodeca[1,2-d][1]benzoxete-2,8(9H)-dione

本站可供应的对应中间体

目录暂未收录该靶点的在售中间体 —— 可直接发起询价,需求会进入撮合池。

本页为中间体 CAS 注册档案:同 CAS 的多条路线登记已合并;后续供应商报价与买方需求以该 CAS 为主键撮合。